-
About Clinect
Clinect offers a complete product management solution to pharmaceutical companies in the Australia and New Zealand markets.
Clinect's core focus is on supporting products at the forefront of patient care.
Clinect provides targeted market access services built on an intimate knowledge of the pharmaceutical market at both the hospital and retail level.
With a dedicated sales force, clinical support services, medical affairs, pharmacovigilance, and regulatory & reimbursement expertise Clinect is your strategic partner in Australia and New Zealand.
Clinect
-
Background
Clinect is a division of Symbion, the largest wholesaler and distributor of pharmaceuticals to hospitals and retail pharmacies in the Australian market.
Symbion is at the heart of pharmacy with 165 years of history and a strong focus on the future of Australian healthcare.
Symbion operates Australia's most extensive and innovative hospital supply-chain network including the servicing of Named Patient Programs.
In 2008, Symbion became part of the Zuellig group, a large, family owned private enterprise with a long and proud heritage of excellence in the distribution of pharmaceutical and healthcare products.
The Zuellig Group has built upon a century of history to own and manage a portfolio of industry-leading healthcare businesses in the Asia Pacific region, with a turnover in excess of US$12 billion.
Clinect has been established in direct response to discussions with our healthcare partners. Clinect assists in bringing to market medicines available overseas to improve patient outcomes in Australia and New Zealand.
Clinect
-
Market Intelligence and Relationships
Clinect's Business Development team has extensive experience in the hospital and speciality pharmaceutical markets.
Success has been driven through established relationships with Directors of Pharmacy and other key decision makers in public hospitals and private healthcare organisations. These relationships also enable identification and access to leading clinicians in specific therapeutic areas as required.
Through strong local relationships, regulatory knowledge and connection with pharmacists and clinicians, Clinect connects your products to the Australian and New Zealand markets.
Clinect
-
Market Access Strategies
Clinect dedicates resources to develop and enable the best market access strategies according to each product and marketplace.
Encompassing registration and Named Patient Programs which include:
- Compassionate Use
- Product Familiarisation
- Early Access
- Special Access Scheme
In partnership with you, Clinect assesses the viability and potential of your product and determines the most appropriate pathway to market.
Clinect has the capability to manage the entire market access process, and ensures all regulatory and reporting requirements are met.
Clinect
-
Regulatory Affairs and Reimbursement
Clinect minimises the requirement for direct regulatory work by international pharmaceutical companies.
An experienced regulatory affairs team is available to work with both the Australian Therapeutic Goods Administration (TGA) and New Zealand's Medsafe to:
- Manage the regulatory submissions and updates to TGA and Medsafe.
- Complete Product Information (PI), Consumer Medical Information (CMI), labelling reviews and requirements for the Australian and New Zealand markets
- Handle all reporting requirements for products in the Australian and New Zealand markets
Clinect provides expert reimbursement advice and support as needed.
An experienced reimbursement team is available to work with both the Australian Pharmaceutical Benefits Advisory Committee (PBAC) and New Zealand's PHARMAC, to advise on opportunities for funding and preparation of submissions to offer your product the best chance of success.
Clinect
-
Pharmacovigilance and Medical Affairs
Clinect provides comprehensive pharmacovigilance and medical information services.
Qualified medical affairs pharmacists offer pharmacovigilance and drug information services to support the ongoing relationships between Clinect, pharmacists and clinicians.
All enquiries are responded to in compliance with Medicines Australia's Code of Conduct requirements.
Adverse events and product complaints are identified, reported and followed up as required by Australian regulatory authorities and your specifications.
Clinect
-
Broader Group Services
Clinect, through Symbion also offers locally based management teams to facilitate further aspects of healthcare logistics, including:
- Pre-Wholesaling services
- Storage and distribution via Wholesale channels
- Cold Chain & Restricted Access inventory management to meet product and regulatory requirements
In addition to the aforementioned services, our group provides:
- Management of Clinical Trial and Comparator products
- Retail solutions directed to Community Pharmacies
- Homecare solutions centred around direct to patient care
Clinect
-
Partnership Opportunities
If you have been looking at entry into the Australian and New Zealand market for your products, we would like to talk to you.
Clinect can offer you a comprehensive solution to achieving a successful entry and continuing presence through both the hospital and retail markets.
Please contact us to see how we can help you further your goals in Australia and New Zealand.
Clinect
